WisdomTree (NYSE:WT – Get Free Report) had its price objective boosted by analysts at The Goldman Sachs Group from $8.50 to $9.50 in a report released on Thursday,Benzinga reports. The firm currently has a “sell” rating on the stock. The Goldman Sachs Group’s price objective indicates a potential downside of 5.47% from the company’s current price.
WisdomTree Stock Performance
WT stock opened at $10.05 on Thursday. The firm has a 50 day simple moving average of $9.14 and a 200 day simple moving average of $9.55. WisdomTree has a 52 week low of $7.47 and a 52 week high of $12.45. The stock has a market cap of $1.48 billion, a P/E ratio of 32.42 and a beta of 1.11. The company has a debt-to-equity ratio of 1.28, a quick ratio of 2.13 and a current ratio of 2.92.
WisdomTree (NYSE:WT – Get Free Report) last posted its quarterly earnings results on Friday, May 2nd. The company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $108.08 million for the quarter, compared to the consensus estimate of $108.47 million. WisdomTree had a net margin of 15.59% and a return on equity of 24.67%. WisdomTree’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.12 earnings per share. Research analysts anticipate that WisdomTree will post 0.72 earnings per share for the current fiscal year.
Hedge Funds Weigh In On WisdomTree
WisdomTree Company Profile
WisdomTree, Inc, through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.
Read More
- Five stocks we like better than WisdomTree
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- Why Are These Companies Considered Blue Chips?
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for WisdomTree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree and related companies with MarketBeat.com's FREE daily email newsletter.